News & Events
Encapsulate Seed Round is Closed with an Oversubscription
Encapsulate Closes $1.8M Oversubscribed Seed Round to Accelerate Personalized Cancer TherapyFarmington, CT – Encapsulate, a developer of personalized oncology solutions, has raised $1.8 million in seed funding, led by Blackwood Healthcare Breakthroughs, Ambit Health...
Encapsulate has won the Entrepreneurship World Cup 2nd Place in KSA
We are thrilled to announce that Encapsulate has secured 2nd place and a $75,000 cash prize at the 2024 Entrepreneurship World Cup Global Finals!Competing among the top 100 startups from 52 countries, Encapsulate was recognized for our advanced tumor-on-a-chip...
Dr. Armin Rad Presented nCapsule’s Exciting Data from On-Orbit Studies
We are thrilled that we have presented at the ISSRDC conference in Boston with our groundbreaking study: "Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity".For the first time, we'll be sharing the incredible data achieved from our...
US Senator Chris Murphy Highlights Farmington’s Encapsulate As “Innovator Of The Month”
HARTFORD–U.S. Senator Chris Murphy (D-Conn.) announced on Friday that Encapsulate, a Farmington-based medtech company founded by two UConn graduates, was named “Innovator of the Month” for their development of a transformative contribution to cancer treatment....
Encapsulate launches its technology to the International Space Station
Yesterday marked a pivotal moment as we witnessed the launch of our cargo destined for the International Space Station, advancing our mission in cancer therapy.On Thursday, March 21 at 4:55 p.m. ET, Falcon 9 launched Dragon’s CRS-30 to the International Space Station...
Dr. Leila Daneshmandi, Co-Founder and COO of Encapsulate Wins 2023 TiE Boston Women Pitch Competition
BOSTON—TiE Boston announced the winners of their highly-anticipated, annual TiE Boston Women’s Pitch Competition, which was held at PTC Headquarters in Boston’s Seaport. Leila Daneshmandi, Co-Founder and COO of Encapsulate won the first prize and will go on to...